Signals, Powered By EquityPandit
Suven Life Sciences has got a patent for a drug that is used in the treatment of neuro-degenerative diseases from China, Eurasia and Hong Kong.
It said in BSE filing that the company has been granted “one product patent from China, one product patent from Eurasia and one product patent from Hong Kong corresponding to the New Chemical Entities (NCEs) for the treatment of disorders associated with Neuro-degenerative diseases.”
The patents will be valid till 2032.
“We are very pleased by the grant of these patents to Suven for our pipeline of molecules in the CNS (central nervous system) arena, which are being developed for cognitive disorders with high unmet medical need with a huge market potential globally.”
